ONESOURCE SPECIALTY PHARMA LIMITED
ONESOURCE SPECIALTY PHARMA LIMITED (India) is linked to 1 FDA-registered manufacturing site. 23 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “ONESOURCE SPECIALTY PHARMA LIMITED: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/onesource-specialty-pharma-limited
Overview
Stelis Biopharma Limited is a fully integrated biopharmaceutical company based in India, specializing in end-to-end solutions from development to commercial manufacturing of biologics and biosimilars. It operates as a subsidiary of Strides Pharma Science Limited.
Core services & business areas
Therapeutic areas
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to ONESOURCE SPECIALTY PHARMA LIMITED, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
23 FDA enforcement records linked to this company.
- recall — Class II2026-07-15
Failed Impurities/Degradation Specifications
- 4832026-06-30
Procedures for sterile drug products
- 4832025-03-28
Absence of Written Procedures
- 4832025-03-28
Validation lacking for sterile drug products
- 4832025-03-28
Procedures for sterile drug products
- 4832025-03-28
Environmental Monitoring System
- 4832024-03-28
Representative Samples
- 4832024-03-28
Procedures for sterile drug products
- 4832024-03-28
Training , Education , Experience overall
- 4832024-03-28
Record maintenance 1 year (except exempt OTC)
- 4832024-03-28
Procedures not in writing, fully followed
- 4832024-03-28
No written record of investigation
- 4832024-03-28
Failing drug products not rejected
- 4832024-03-28
Acceptance of drug products
- 4832019-12-20
Investigations of discrepancies, failures
- 4832019-02-14
Equipment Design, Size and Location
- 4832018-03-13
Representative Samples
- 4832018-03-13
Procedures for sterile drug products
- 4832018-03-13
Control procedures to monitor and validate performance
- 4832018-03-13
Written record of investigation incomplete
- warning_letter2015-08-07
FDA Warning Letter (drug product)
- 4832011-09-29
In-process materials specifications testing
- 4832011-09-29
Investigations of discrepancies, failures
Is this ONESOURCE SPECIALTY PHARMA LIMITED?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.